News Column

Studies from University of Hannover Have Provided New Information about Nanoparticles (Aptamer-modified nanoparticles as biosensors)

July 16, 2014

By a News Reporter-Staff News Editor at Biotech Week -- New research on Nanoparticles is the subject of a report. According to news originating from Hannover, Germany, by NewsRx correspondents, research stated, "Aptamers are short oligonucleotides that are capable of selectively binding to their corresponding target. Therefore, they can be thought of as a nucleic acid-based alternative to antibodies and can substitute for their amino acid-based counterparts in analytical applications, including as receptors in biosensors."

Our news journalists obtained a quote from the research from the University of Hannover, "Here they offer several advantages because their nucleic acid nature and their binding via an induced fit mechanism enable novel sensing strategies. In this article, the utilization of aptamers as novel bio-receptors in combination with nanoparticles as transducer elements is reviewed."

According to the news editors, the research concluded: "In addition to these analytical applications, the medical relevance of aptamer-modified nanoparticles is described."

For more information on this research see: Aptamer-modified nanoparticles as biosensors. Advances In Biochemical Engineering, 2014;140():121-54 (see also Nanoparticles).

The news correspondents report that additional information may be obtained from M. Lonne, Institut fur Technische Chemie, Gottfried Wilhelm Leibniz Universitat Hannover, Callinstr 5, 30167, Hannover, Germany. Additional authors for this research include G. Zhu, F. Stahl and J.G Walter.

Keywords for this news article include: Europe, Germany, Hannover, Biosensing, Bioengineering, Bionanotechnology, Nanobiotechnology, Emerging Technologies.

Our reports deliver fact-based news of research and discoveries from around the world. Copyright 2014, NewsRx LLC

For more stories covering the world of technology, please see HispanicBusiness' Tech Channel

Source: Biotech Week

Story Tools Facebook Linkedin Twitter RSS Feed Email Alerts & Newsletters